Published July 26, 2023

On-Demand Webinars: “2024 Proposed Payment Rules — Parts 1 & 2”

Twice each month, PYA experts discuss the latest industry regulatory developments during our popular Healthcare Regulatory Roundup webinar series. A two-part session on July 12 and July 26 addressed 2024 proposed payment rules.

“2024 Proposed Rules Part 1”

Presented Wednesday, July 12, 2023.

CMS released the following proposed payment rules for calendar year 2024. PYA’s Martie Ross and Kathy Reep discussed key provisions and highlighted their impacts. This webinar addressed the following rules: 

  • CY 2024 Hospital Outpatient PPS Proposed Rule
  • Remedy for 340B-Acquired Drug Payment Policy for CYs 2018-2022 Proposed Rule
  • CY 2024 Home Health PPS Proposed Rule
  • CY 2024 ESRD PPS Proposed Rule
  • Request for Information  – Medical Payment Projects
  • The Latest No Surprises Act FAQs



“2024 Proposed Rules Part 2 – Hospital OPPS and Medicare Physician Fee Schedule

Presented Wednesday, July 26, 2023.

On July 13, CMS released the 2024 Hospital OPPS and Medicare Physician Fee Schedule proposed rules. PYA’s Martie Ross and Kathy Reep presented this 90-minute webinar diving deep into proposed payment and policy changes, including the following:

2024 Hospital OPPS Proposed Rule

  • 2.8% payment rate update
  • New benefit category for Intensive Outpatient Program services
  • Changes to and enforcement of hospital price transparency requirements
  • Separate payment for establishing and maintaining buffer stock of essential medicines
  • Quality reporting program changes

 2024 Medicare Physician Fee Schedule

  • 3.34% reduction in conversion factor (from $33.89 to is $32.75)
  • E/M add-on code for complex patients
  • Delay in changes to split/shared visit billing rules
  • New payment for caregiver training services, community health integration services, social determinants of health risk assessment, and principal illness navigation services
  • Telehealth policy changes




If you would like assistance with evaluating regulatory impacts or any matter involving compliance, valuation, or strategy and transactions, one of our executive contacts would be happy to assist. You may email them below or call (800) 270-9629.

Executive Contacts

Interested in Learning More?

Sign Up for Our Latest Thought Leadership!

    Select Your Subscriptions